Literature DB >> 9418730

Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells.

R N Weinreb1, K Kashiwagi, F Kashiwagi, S Tsukahara, J D Lindsey.   

Abstract

PURPOSE: To identify matrix metalloproteinases (MMPs) released by ciliary smooth muscle cells in vitro and to determine whether MMP release is altered by exposure to prostaglandins (PGs).
METHODS: Human ciliary smooth muscle cells were grown to confluence in monolayer cultures and treated with PGF2 alpha, 11-deoxy-PGE1, or PhXA85 (the nonesterified analogue of PhXA41) for 12 to 72 hours. The activity of MMP in the medium was assayed using gelatin and casein zymography. Identification of the specific MMP associated with each band was made by Western blot analysis. Band intensity, which reflects activity, was measured with a scanning laser densitometer.
RESULTS: Three major bands appeared in the gelatin zymographs at positions corresponding to molecular weights of 62 kDa, 68 kDa, and 97 kDa. A single band at 50 kDa predominated in the casein zymograms. Substitution of EDTA for calcium and zinc in the development solution eliminated the appearance of these bands, indicating that they reflect MMP activity. Immunoblotting, using MMP-specific antibodies, confirmed that the three bands in the gelatin zymographs were MMP-1, MMP-2, and MMP-9, respectively; the single band in the casein zymographs was MMP-3. Treatment with 200 nM PGF2 alpha, 11-deoxy-PGE1, or PhXA85 for 72 hours increased the combined density scores for MMP-1 and MMP-2 by 37%, 64%, and 27%; the density scores for MMP-9 by 268%, 253%, and 125%; and the density scores for MMP-3 by 35%, 71%, and 22%, respectively.
CONCLUSIONS: These results indicate that ciliary smooth muscle cells can secrete MMP-1, MMP-2, MMP-3, and MMP-9. In addition, exposure to PGF2 alpha, 11-deoxy-PGE1, or PhXA85 increases production of all four MMPs. These observations support the hypothesis that increased MMP production by ciliary muscle cells has a role in increasing uveoscleral outflow facility after topical PG administration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9418730

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  42 in total

1.  Relation between axial length of the eye and hypotensive effect of latanoprost in primary open angle glaucoma.

Authors:  E Arranz-Marquez; M A Teus
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

2.  Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension.

Authors:  T Chiba; K Kashiwagi; N Chiba; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

3.  Can NSAIDs and prostaglandin analogues be combined?

Authors:  A Alm
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

4.  A case of keratoconus progression associated with the use of topical latanoprost.

Authors:  Shiro Amano; Yoshiyuki Nakai; Akiko Ko; Kenji Inoue; Masato Wakakura
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

5.  The change of anterior segment parameters after cataract surgery in normal-tension glaucoma.

Authors:  Wonseok Lee; Hyoung Won Bae; Chan Yun Kim; Gong Je Seong
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

6.  Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments.

Authors:  Cindy K Bahler; Kyle G Howell; Cheryl R Hann; Michael P Fautsch; Douglas H Johnson
Journal:  Am J Ophthalmol       Date:  2007-11-07       Impact factor: 5.258

7.  Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study.

Authors:  K Sheng Lim; Cherie B Nau; Megan M O'Byrne; David O Hodge; Carol B Toris; Jay W McLaren; Douglas H Johnson
Journal:  Ophthalmology       Date:  2008-05       Impact factor: 12.079

8.  Latanoprost-induced changes in rat intraocular pressure: direct or indirect?

Authors:  Shahid Husain; Phillip W Yates; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2008-08       Impact factor: 2.671

9.  Ciliary body thickness and refractive error in children.

Authors:  Melissa D Bailey; Loraine T Sinnott; Donald O Mutti
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

10.  Secreted protein acidic and rich in cysteine (SPARC)-null mice exhibit more uniform outflow.

Authors:  Swarup S Swaminathan; Dong-Jin Oh; Min Hyung Kang; Ruiyi Ren; Rui Jin; Haiyan Gong; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-21       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.